Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Devices & Dosimetry

Laser Acupuncture on the Management of Xerostomia in Sjögren's Disease: A Randomized Clinical Trial

PBM at acupuncture points demonstrated a slight short-term benefit at week 8 in improving xerostomia symptoms and RSFR, although these effects did not persist at 12 weeks.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors report a randomized, double-blind trial in which 50 patients with Sjögren's disease received photobiomodulation or sham treatment at acupuncture points for four weeks. They found only a marginal, non-significant trend toward better xerostomia symptoms and salivary flow at week 8, with no significant differences by week 12.

Participants
50
Who or what was studied
Patients with Sjögren's Disease and xerostomia
Limits stated in the abstract
The abstract reports only marginal, non-statistically significant short-term trends that did not persist at 12 weeks, and the authors call for larger, long-term trials to validate the preliminary results.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Objectives

This study evaluated the efficacy of photobiomodulation (PBM) at acupuncture points for managing xerostomia in patients with Sjögren's Disease.

Material And Methods

In this randomized, double-blind clinical trial, 50 patients were assigned to PBM group (n = 22) or sham-PBM group (n = 28). The primary outcome was xerostomia symptoms assessed using a visual analogue scale (VAS). Secondary outcomes included Xerostomia Inventory, resting salivary flow rate (RSFR), and EULAR Sjögren's Syndrome Patient Reported Index score. Participants received weekly PBM sessions for four consecutive weeks, and evaluations were conducted at baseline, week 8 and 12.

Results

PBM showed a marginal tendency toward improvement on VAS (p = 0.0974) (OR = 1.929 95% CI 0.8939-4.525) and in the RSFR (p = 0.09996) (OR = +infinity 95% CI 0.9363-infinity) at week 8 compared with sham-PBM. However, no statistically significant differences were observed between groups at week 12 for any of the assessed outcomes.

Conclusion

PBM at acupuncture points demonstrated a slight short-term benefit at week 8 in improving xerostomia symptoms and RSFR, although these effects did not persist at 12 weeks. These preliminary results suggest a potential role for PBM at acupuncture points as a safe, noninvasive adjunctive therapy for xerostomia in patients with SjD, warranting further validation in larger, long-term trials.

Trial Registration

This study was registered in The Brazilian Registry of Clinical Trials (U1111-1298-9891).

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

How to read a trial: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Laser, Visual analogue scale, Sham, Trial registration, Primary outcome. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies